Formulation and Evaluation of Extended-Release Bilayer Tablets Containing Empagliflozin and Metformin Hydrochloride for Diabetes Mellitus Management
Abstract
This study systematically evaluates the formulation development of bilayer tablets combining Empagliflozin and Metformin hydrochloride for diabetes mellitus management. The formulation design encompassed drug-excipient compatibility, flow characteristics, and the development of immediate and extended-release layers. Differential Scanning Calorimetry (DSC) confirmed compatibility between Empagliflozin, Metformin hydrochloride, and selected excipients (HPMC and Avicel), showing no significant variations in onset and peak melting points after 4 weeks of incubation. Flow properties were assessed and demonstrating excellent flow characteristics suitable for tablet formulation. Both pre and post- compression analysis were found to be within pharmacopoeial limits. In an attempt to define the best formulation parameters, a concept known as Central Composite Design (CCD) as well as Full Factorial Design (FD) were used. CCD experiments pointed to the strong impact of Hydroxypropyl cellulose and Croscarmellose content on the tableting properties. It was useful while employing the FD method in conducting a comprehensive evaluation of several factors affecting Empagliflozin formulation to accomplish optimization. This detailed investigation underscores the importance of systematic assessments in formulating bilayer tablets with Empagliflozin and Metformin hydrochloride, ensuring stability, efficacy, and compliance, ultimately contributing to advancements in drug delivery systems and improved patient outcomes.
Keywords:
Bilayer tablets, Empagliflozin, Metformin hydrochloride, Formulation development, Systematic studyDOI
https://doi.org/10.25004/IJPSDR.2024.160505References
Chinta R, Rohini P. Formulation development of Empagliflozin and Metformin hydrochloride extended-release Tablets: Optimization of Formulation using statistical experimental design. Research Journal of Pharmacy and Technology. 2021;14(3):1201-8. http://dx.doi.org/10.5958/0974-360X.2021.00214.6
Kumar A, Mazumder R, Rani A, Pandey P, Khurana N. Novel Approaches for the Management of Type 2 Diabetes Mellitus: An Update. Current Diabetes Reviews. 2024 May 1;20(4):45-61. https://doi.org/10.2174/0115733998261903230921102620
Tomlinson B, Li YH. Canagliflozin+ metformin ER for the treatment of type 2 diabetes: the evidence to date. Expert Opinion on Pharmacotherapy. 2023 Dec 12;24(18):1937-47. https://doi.org/10.1080/14656566.2023.2276180
S Simos YV, Spyrou K, Patila M, Karouta N, Stamatis H, Gournis D, Dounousi E, Peschos D. Trends of nanotechnology in type 2 diabetes mellitus treatment. Asian journal of pharmaceutical sciences. 2021 Jan 1;16(1):62-76. https://doi.org/10.1016/j.ajps.2020.05.001
Wilkins CA, Hamman H, Hamman JH, Steenekamp JH. Fixed-dose combination formulations in solid oral drug therapy: Advantages, limitations, and design features. Pharmaceutics. 2024 Jan 26;16(2):178. https://doi.org/10.3390/pharmaceutics16020178
Arya G, Mamgain S, Saxena A. Formulation And Evaluation Of Bilayer Tablets For The Treatment Of Diabetes. Educational Administration: Theory and Practice. 2024 Jun 19;30(6):3437-45. https://doi.org/10.53555/kuey.v30i6.5833
Fu Q, Su X, Hou Y, Li M, Li J, Sun J, He Z. Once-daily amoxicillin immediate-and extended-release bilayer tablets. Powder Technology. 2016 Nov 1;301:405-11. https://doi.org/10.1016/j.powtec.2016.06.030
He W, Li Y, Zhang R, Wu Z, Yin L. Gastro-floating bilayer tablets for the sustained release of metformin and immediate release of pioglitazone: Preparation and in vitro/in vivo evaluation. International journal of pharmaceutics. 2014 Dec 10;476(1-2):223-31. https://doi.org/10.1016/j.ijpharm.2014.09.056
Mishra BI, Mohanty BI. Once-daily immediate and extendedrelease bilayer tablets of etoricoxib: a study on the release kinetics. Int J Appl Pharm. 2019 Sep 7;1:230-5. http://dx.doi.org/10.22159/ijap.2019v11i5.31638
Joseph D, Thomas GM. A review on current applications of bilayer tablets. Research Journal of Pharmacy and Technology. 2019;12(5):2539-44. http://dx.doi.org/10.5958/0974-360X.2019.00427.X
Nirmal J, Saisivam S, Peddanna C, Muralidharan S, Godwinkumar S, Nagarajan M. Bilayer tablets of atorvastatin calcium and nicotinic acid: formulation and evaluation. Chemical and Pharmaceutical Bulletin. 2008 Oct 1;56(10):1455-8. https://doi.org/10.1248/cpb.56.1455
Parhi R, Bhupati SK, Suresh P, Kumar V. Formulation and evaluation of bilayer sustained release tablet of zolpidem tartrate. Indones J Pharm. 2013 Oct 1;24(4):289-98. https://doi.org/10.14499/indonesianjpharm24iss4pp289
Kar AK, Majumder T, Majumdar S, Mahanti B, Kar B, Chakraborty S, Parya H, Saha S. Design, formulation and evaluation of sustained release bilayer tablets of ciprofloxacin hydrochloride. Journal of Drug Delivery and Therapeutics. 2019 Jan 15;9(1):46-53. https://doi.org/10.22270/jddt.v9i1.2158
Nazim S, Ahmed A, Patel S. Formulation and evaluation of bilayer tablets of metoprolol succinate. Research Journal of Pharmacy and Technology. 2015;8(3):292-9. http://dx.doi.org/10.5958/0974-360X.2015.00049.9
Momin MM, Kane S, Abhang P. Formulation and evaluation of bilayer tablet for bimodal release of venlafaxine hydrochloride. Frontiers in pharmacology. 2015 Jul 9;6:144. https://doi.org/10.3389/fphar.2015.00144
Dey S, Chattopadhyay S, Mazumder B. Formulation and Evaluation of Fixed‐Dose Combination of Bilayer Gastroretentive Matrix Tablet Containing Atorvastatin as Fast‐Release and Atenolol as Sustained‐Release. BioMed research international. 2014;2014(1):396106. https://doi.org/10.1155/2014/396106
Nguyen NN, Pham DT, Nguyen DT, Trinh TT. Bilayer tablets with sustained-release metformin and immediate-release sitagliptin: preparation and in vitro/in vivo evaluation. Journal of Pharmaceutical Investigation. 2021 Sep;51(5):579-86. https://doi.org/10.1007/s40005-021-00533-z
Dey S, Mahanti B, Khila S, Mazumder B, Gupta SD. Formulation development and optimization of bilayer tablets of aceclofenac. Expert opinion on drug delivery. 2012 Sep 1;9(9):1041-50. https://doi.org/10.1517/17425247.2012.707187
Nguyen NN, Pham DT, Nguyen DT, Trinh TT. Bilayer tablets with sustained-release metformin and immediate-release sitagliptin: preparation and in vitro/in vivo evaluation. Journal of Pharmaceutical Investigation. 2021 Sep;51(5):579-86. https://link.springer.com/article/10.1007/S40005-021-00533-Z
Ryakala H, Dineshmohan S, Ramesh A, Gupta VR. Formulation and in vitro evaluation of bilayer tablets of nebivolol hydrochloride and nateglinide for the treatment of diabetes and hypertension. Journal of drug delivery. 2015;2015(1):827859. https://doi.org/10.1155/2015/827859
Published
Abstract Display: 36 
PDF Downloads: 4 How to Cite
Issue
Section
Copyright (c) 2024 Krishna Deore, Mohammad Ismail Mouzan
This work is licensed under a Creative Commons Attribution 4.0 International License.
